Clinical Trials
3 trialsNCT06070961 2025-06-29
FIL_FollVax22
Fondazione Italiana Linfomi - ETS
Recruiting
NCT00337428 2016-11-16
Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00325130 2015-03-12
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)
Merck Sharp & Dohme LLC
Phase 3 Completed